Article
APOE-amyloid interaction: Therapeutic targets.
Neurobiology of disease - 1 May 2020
Wisniewski Thomas, Drummond Eleanor
Abstract excerpt
Alzheimer's disease (AD) is a devastating neurodegenerative disorder that is growing in prevalence globally. It is the only major cause of death without any effective pharmacological means to treat or slow progression. Inheritance of the ε4 allele of the Apolipoprotein (APO) E gene is the strongest genetic risk factor for late-onset AD. The interaction between APOE and amyloid β (Aβ) plays a key role in AD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
